Cargando…
Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract
Spirulina platensis contains several compounds showing nutritional and therapeutic benefits. Recently, a series of peptides able to reduce the blood pressure level and to enhance the endothelial vasorelaxation was isolated from the hydrolyzed highly water-soluble Spirulina extract (HSE). However, HS...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248919/ https://www.ncbi.nlm.nih.gov/pubmed/32365705 http://dx.doi.org/10.3390/molecules25092086 |
_version_ | 1783538482524717056 |
---|---|
author | Aquino, Rita P. Auriemma, Giulia Conte, Giulio M. Esposito, Tiziana Sommella, Eduardo Campiglia, Pietro Sansone, Francesca |
author_facet | Aquino, Rita P. Auriemma, Giulia Conte, Giulio M. Esposito, Tiziana Sommella, Eduardo Campiglia, Pietro Sansone, Francesca |
author_sort | Aquino, Rita P. |
collection | PubMed |
description | Spirulina platensis contains several compounds showing nutritional and therapeutic benefits. Recently, a series of peptides able to reduce the blood pressure level and to enhance the endothelial vasorelaxation was isolated from the hydrolyzed highly water-soluble Spirulina extract (HSE). However, HSE shows critical organoleptic characteristics also having poor intestinal permeability, limiting absorption when orally delivered. This research aims to overcome the critical issues through the encapsulation of HSE in Chitosan/Mannitol—(CM)-based microparticles by spray drying. The produced powders (CM-HSE) showed good process yield (≈70%) and encapsulation efficiency (≈100%) also having good derived flow properties as well as stability up to six months storage. The microparticles constituting the spray-dried powder resulted in an amorphous micrometric state (d(50) ≈ 14 µm) able to retain dark colour and unpleasant smell of raw HSE. Moreover, the in vitro permeation study by Franz cell indicated that the engineered microparticles are able to enhance the permeation of HSE through an intestinal biomimetic barrier (551.13 μg/cm(2) CM-HSE vs. 315.46 μg/cm(2) HSE at 270 min). |
format | Online Article Text |
id | pubmed-7248919 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72489192020-06-10 Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract Aquino, Rita P. Auriemma, Giulia Conte, Giulio M. Esposito, Tiziana Sommella, Eduardo Campiglia, Pietro Sansone, Francesca Molecules Article Spirulina platensis contains several compounds showing nutritional and therapeutic benefits. Recently, a series of peptides able to reduce the blood pressure level and to enhance the endothelial vasorelaxation was isolated from the hydrolyzed highly water-soluble Spirulina extract (HSE). However, HSE shows critical organoleptic characteristics also having poor intestinal permeability, limiting absorption when orally delivered. This research aims to overcome the critical issues through the encapsulation of HSE in Chitosan/Mannitol—(CM)-based microparticles by spray drying. The produced powders (CM-HSE) showed good process yield (≈70%) and encapsulation efficiency (≈100%) also having good derived flow properties as well as stability up to six months storage. The microparticles constituting the spray-dried powder resulted in an amorphous micrometric state (d(50) ≈ 14 µm) able to retain dark colour and unpleasant smell of raw HSE. Moreover, the in vitro permeation study by Franz cell indicated that the engineered microparticles are able to enhance the permeation of HSE through an intestinal biomimetic barrier (551.13 μg/cm(2) CM-HSE vs. 315.46 μg/cm(2) HSE at 270 min). MDPI 2020-04-29 /pmc/articles/PMC7248919/ /pubmed/32365705 http://dx.doi.org/10.3390/molecules25092086 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Aquino, Rita P. Auriemma, Giulia Conte, Giulio M. Esposito, Tiziana Sommella, Eduardo Campiglia, Pietro Sansone, Francesca Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract |
title | Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract |
title_full | Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract |
title_fullStr | Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract |
title_full_unstemmed | Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract |
title_short | Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract |
title_sort | development of chitosan/mannitol microparticles as delivery system for the oral administration of a spirulina bioactive peptide extract |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248919/ https://www.ncbi.nlm.nih.gov/pubmed/32365705 http://dx.doi.org/10.3390/molecules25092086 |
work_keys_str_mv | AT aquinoritap developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract AT auriemmagiulia developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract AT contegiuliom developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract AT espositotiziana developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract AT sommellaeduardo developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract AT campigliapietro developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract AT sansonefrancesca developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract |